MedTrace Logo

Addition of Computer Simulations to Minimize Adverse Events After Transcatheter Aortic Valve Implantation

NCT04473443 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-07-27

No results posted yet for this study

Summary

The objective is to assess the influence of FEops HEARTguide on overall device success in TAVI patients with challenging anatomies (Cohort A) or in transcatheter heart valve (THV) platform selection (Cohort B).

Conditions

  • Aortic Valve Stenosis
  • Bicuspid Cardiac Valve

Interventions

OTHER

FEops HEARTguideTM

A patient-specific computer simulation that aims to improve the outcomes after TAVI by suggesting THV platform, THV size and implantation depth with the use of the pre-procedural CT-scan.

Sponsors & Collaborators

Principal Investigators

  • Nicolas van Mieghem, Md,PhD · Erasmus Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2023-02-01
Completion
2023-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04473443 on ClinicalTrials.gov